menu
    • menu

    Company profile for Alligator Bioscience

    NEW Drugs in Dev.: 6
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alligator BioscienceSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village, 223 81 Lund,
    Telephone
    Telephone
    + 46 (0)46 286 4280
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alligatorbioscience.se/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alligator Bioscience Unveils Mitazalimab OPTIMIZE-1 Data At ASCO
    Alligator Bioscience Unveils Mitazalimab OPTIMIZE-1 Data At ASCO

    09 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-09/alligator-bioscience-to-present-new-optimize-1-data-on-mitazalimab-at-asco-gastrointestinal-cancers

    PHARMIWEB
    09 Jan 2026
    Share Share
    Alligator Bio Announces Preliminary Outcome in Rights Issue
    Alligator Bio Announces Preliminary Outcome in Rights Issue

    19 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-19/alligator-bioscience-announces-preliminary-outcome-in-rights-issue

    PHARMIWEB
    19 Dec 2025
    Share Share
    Alligator Bioscience Publishes Financial Calendar For 2026
    Alligator Bioscience Publishes Financial Calendar For 2026

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/alligator-bioscience-publishes-financial-calendar-for-2026

    PHARMIWEB
    03 Dec 2025
    Share Share
    Alligator Publishes Supplement Prospectus
    Alligator Publishes Supplement Prospectus

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/alligator-publishes-supplement-prospectus

    PHARMIWEB
    03 Dec 2025
    Share Share
    Alligator Bioscience Adds New Rights Commitments
    Alligator Bioscience Adds New Rights Commitments

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/alligator-bioscience-enters-into-additional-subscription-undertakings-and-top-guarantee-commitments

    PHARMIWEB
    01 Dec 2025
    Share Share
    Alligator Bio Announces Reactive-2 Phase 1 Trial Data Publication
    Alligator Bio Announces Reactive-2 Phase 1 Trial Data Publication

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/alligator-bioscience-announces-publication-of-reactive-2-phase-1-trial-data-in-nature-communications

    PHARMIWEB
    01 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search